Merck KGaA (FRA:MRK) has been assigned a €95.00 ($102.15) price objective by equities research analysts at HSBC in a report released on Thursday. The firm currently has a “neutral” rating on the stock.

MRK has been the topic of a number of other reports. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Merck KGaA in a report on Friday, October 14th. Citigroup Inc. set a €115.00 ($123.66) price target on Merck KGaA and gave the company a “buy” rating in a report on Thursday, September 29th. BNP Paribas set a €114.00 ($122.58) price target on Merck KGaA and gave the company a “buy” rating in a report on Friday, September 30th. Commerzbank AG set a €101.00 ($108.60) price target on Merck KGaA and gave the company a “buy” rating in a report on Friday, October 14th. Finally, Berenberg Bank set a €101.00 ($108.60) price target on Merck KGaA and gave the company a “neutral” rating in a report on Tuesday, November 15th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have given a buy rating to the stock. Merck KGaA has an average rating of “Hold” and an average price target of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) opened at 95.35 on Thursday. Merck KGaA has a one year low of €70.87 and a one year high of €100.00. The company has a market capitalization of €41.50 billion and a P/E ratio of 27.89. The stock’s 50 day moving average price is €95.54 and its 200-day moving average price is €92.98.

About Merck KGaA

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.